| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/23/1998 | EP0865419A1 Indane dimer compounds and their pharmaceutical use |
| 09/23/1998 | EP0865339A1 Metalloproteinase inhibitors |
| 09/23/1998 | EP0865298A1 Drug therapy |
| 09/23/1998 | EP0865297A1 Vaccine compositions for intranasal administration comprising chitosan and use thereof |
| 09/23/1998 | EP0865296A1 Influenza vaccine |
| 09/23/1998 | EP0865294A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 09/23/1998 | EP0865293A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/23/1998 | EP0865292A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 09/23/1998 | EP0865291A1 Localized intravascular delivery of tfpi for inhibition of restenosis in recanalized blood vessels |
| 09/23/1998 | EP0865290A1 Pharmaceutical compositions for oral use including an nsaid and ceramides |
| 09/23/1998 | EP0865288A2 Bioartificial devices and cellular matrices therefor |
| 09/23/1998 | EP0865286A1 Compositions, comprising bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders |
| 09/23/1998 | EP0865285A1 Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders |
| 09/23/1998 | EP0865284A1 Compositions, containing bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders |
| 09/23/1998 | EP0865283A1 2-deoxystreptamine as a molecular scaffold for preparing functionally and spacially diverse molecules and pharmaceutical compositions thereof |
| 09/23/1998 | EP0865281A1 Naphthyl-substituted benzimidazole derivatives as anticoagulants |
| 09/23/1998 | EP0865280A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 09/23/1998 | EP0865279A1 Hemoregulatory compounds |
| 09/23/1998 | EP0865278A1 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat |
| 09/23/1998 | EP0865277A1 Use of fungicidal agents for selective decontamination of teeth and dental prostheses |
| 09/23/1998 | EP0865276A1 Polyamine derivatives of 1-aminoindan |
| 09/23/1998 | EP0865275A2 Graft survival prolongation with porphyrins |
| 09/23/1998 | EP0764169B1 Drug salts |
| 09/23/1998 | EP0729469B1 IMIDAZO [1,5-a]QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS |
| 09/23/1998 | EP0714393B1 Thiazoles as antiviral |
| 09/23/1998 | EP0711280B1 Perhydroisoindole derivatives as p substance antagonists |
| 09/23/1998 | EP0700383B1 Novel 1-phenylalkanone 5-ht 4? receptor ligands |
| 09/23/1998 | EP0700285B1 A drug delivery composition for alpha-adreno receptor blocking agents |
| 09/23/1998 | EP0695176B1 Solid form of administration of isosorbide 5-mononitrate |
| 09/23/1998 | EP0693077B1 Antiviral compounds |
| 09/23/1998 | EP0689535B1 Benzimidazole derivatives |
| 09/23/1998 | EP0680321B1 Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
| 09/23/1998 | EP0674637B1 Quinuclidine derivatives as squalene synthase inhibitors |
| 09/23/1998 | EP0618916B1 Anti-rheumatic naphthyridine derivatives |
| 09/23/1998 | EP0597025B1 Use of a tocopherol phosphate or one of its derivatives, for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
| 09/23/1998 | EP0586378B1 Novel platinum(ii) complex and processes for preparing the same |
| 09/23/1998 | EP0539421B1 Novel oxazolyl derivatives |
| 09/23/1998 | EP0527232B1 Thiazolidine-2,4-dione derivative, salt thereof, and production thereof |
| 09/23/1998 | EP0526658B1 Thiazolidine-2,4-dione derivative, salt thereof, and production of the same |
| 09/23/1998 | CN1194009A 结肠特异性基因及蛋白质 Colon-specific genes and proteins |
| 09/23/1998 | CN1193979A Macrolides |
| 09/23/1998 | CN1193978A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 09/23/1998 | CN1193975A Isolation of clavulanic acid from fermentation broth by ultrafiltration |
| 09/23/1998 | CN1193974A £1,2,4| triazolo £4,3-1| quinoxalinone derivatives, their preparation and use |
| 09/23/1998 | CN1193973A £1,2,4| triazolo £4,3-a| quinoxalinone derivatives, their preparation and use |
| 09/23/1998 | CN1193972A Heterocyclic compounds for treating myocardial ischaemia |
| 09/23/1998 | CN1193968A 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 09/23/1998 | CN1193966A Aromatic compounds and pharmaceutical compositions containing them |
| 09/23/1998 | CN1193965A 10-acyloxy-10,11-dihydrodibenz/b, f/azepine-5-carboxamides useful for treating nervous system disorders |
| 09/23/1998 | CN1193964A Benzo£g| quinoline derivatives |
| 09/23/1998 | CN1193963A Aromatic compounds and pharmaceutical compositions containing them |
| 09/23/1998 | CN1193961A Substituted benzylaminopiperidine compounds |
| 09/23/1998 | CN1193952A Heterocyclic methyl free radicals as image enhancing agents |
| 09/23/1998 | CN1193915A Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 09/23/1998 | CN1193913A Compounds and pharmaceutical compositions containing them |
| 09/23/1998 | CN1193912A Use of L-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral |
| 09/23/1998 | CN1193911A Use of basic amino acids and derivatives for lowering ceramide levels |
| 09/23/1998 | CN1193910A Use of alicyclic diamines as immunomodulators |
| 09/23/1998 | CN1193909A Water activable viscous compositions containing tetracainum |
| 09/23/1998 | CN1193906A Therapeutic effervescent compositions |
| 09/23/1998 | CN1193894A Two-stage preparation |
| 09/23/1998 | CN1193627A Platinum (IV) complex and pharmaceutical composition comprising the same |
| 09/23/1998 | CN1193623A Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| 09/23/1998 | CN1193513A Use of pyrimidine derivatives for prevention of cancer, on their own or in combination with other therapeutic measures |
| 09/23/1998 | CN1193512A Application of tea component in preparation of pharmaceutics for leukemia |
| 09/23/1998 | CN1039911C Galanthamine derivatives, a process for their preparation and use as medicaments |
| 09/23/1998 | CN1039910C Galanthamine derivatives, a process for their preparation and use as medicaments |
| 09/23/1998 | CN1039909C Aminobenzoic acid derivatives |
| 09/23/1998 | CN1039908C Tricyclic diazepine vasopressin antagonists |
| 09/23/1998 | CN1039907C Methotrexate derivative |
| 09/23/1998 | CN1039906C Heteraryloxy-beta-carboline, process for its production and use in pharmaceutical agents |
| 09/22/1998 | USRE35903 Slow-release preparation of diltiazem, and a medicine provided thereby |
| 09/22/1998 | US5811609 Milling in the presence of hydrocolloid to form a suspension; melting, cooling, finely dividing, drying; amorphous, higher bioavailability |
| 09/22/1998 | US5811600 Glycerol enhanced rehydration formulation |
| 09/22/1998 | US5811582 Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients |
| 09/22/1998 | US5811576 1-carboxy-2-loweralkyl-3,4,6-tri(halo)benzenes; grampositive and-negative bacteria; infections; sterilization of medical equipment |
| 09/22/1998 | US5811568 Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity |
| 09/22/1998 | US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis |
| 09/22/1998 | US5811558 Process for the resolution of etodolac using glucamine derivatives |
| 09/22/1998 | US5811553 Quinoline derivatives(2) |
| 09/22/1998 | US5811549 Process of preparing imidazole compounds |
| 09/22/1998 | US5811548 Tri-and tetracyclic compounds |
| 09/22/1998 | US5811542 Method for producing soluble glucans |
| 09/22/1998 | US5811537 Antisense oligonucleotides targeted against human immunodeficiency virus |
| 09/22/1998 | US5811535 Human cartilege gp39-like gene |
| 09/22/1998 | US5811534 Purine-based compounds for inclusion into oligonucleotides |
| 09/22/1998 | US5811520 Human phospholipase inhibitor protein |
| 09/22/1998 | US5811464 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, virus or protozoan infections as well as for immunomodulation |
| 09/22/1998 | US5811463 Compositions and method for relaxing smooth muscles |
| 09/22/1998 | US5811459 Pain relievers |
| 09/22/1998 | US5811457 Therapeutical method for treating chronic arteriosclerosis obliterans |
| 09/22/1998 | US5811456 Treatment of alzheimer's disease |
| 09/22/1998 | US5811455 Compounds useful for treating allergic or inflammatory diseases |
| 09/22/1998 | US5811454 3-fluorobenzamides with nitrogen mustard groups; anticarcinogenic agents |
| 09/22/1998 | US5811453 Viscoelastic compositions and methods of use |
| 09/22/1998 | US5811452 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| 09/22/1998 | US5811451 Antiinflammatory agents; infections; osteoporosis; autoimmune diseases; human and veterinary medicine; cattle, dogs, horses; gastrointestinal and respiratory dsystem disorders; glandular disorders |
| 09/22/1998 | US5811450 Diagnosis, treatment of hiv |
| 09/22/1998 | US5811449 Administering a suppressor pyrrolidine dithiocarbamate to prevent the oxidation of a polyunsaturated fatty acid |
| 09/22/1998 | US5811448 Pharmaceuticals useful for the treatment of cardiac arrhythmias |